세계의 지카바이러스 검사 시장 : 산업 규모, 점유율, 동향, 기회, 예측 - 검사 유형별(핵산 증폭 검사(NAAT), 혈청학적 검사), 지역별, 경쟁별(2020-2030년)

Zika Virus Testing Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type (Nucleic Acid Amplification Testing (NAAT), Serological Testing), By Region & Competition, 2020-2030F

US $ 4,500 ￦ 6,258,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 7,649,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,126,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

세계의 지카바이러스 검사 시장은 2024년에 1억 6,223만 달러로 평가되었고, 2030년까지 연평균 복합 성장률(CAGR) 6.42%로 성장할 것으로 예측됩니다.

이 시장은 모기가 매개하는 병원체인 지카바이러스를 검출하는 데 사용되는 진단 기술에 초점을 두고 있으며, 특히 감염된 산모로부터 태어난 유아의 선천성 이상과 같은 심각한 건강 결과와 관련하여 알려져 있습니다. 검사 방법은 PCR과 같은 분자진단, 혈청학적 분석, 신속한 진단 테스트 등이 있습니다. 이러한 솔루션에 대한 수요는, 지역적인 유행 시에 강해져, 자주 신속한 공중 위생 대응이 요구됩니다. 지카열로 인한 임산부와 신생아의 건강 영향에 대한 인식 제고 및 감염병 대비를 강화하는 세계의 노력이 시장의 꾸준한 확대에 기여하고 있습니다. CDC 같은 기관은 특히 바이러스가 가장 높은 위험을 초래하는 임신 초기 조기 발견의 중요성을 강조하고 있습니다. 이 분야는, 새로운 매개 감염병의 위협에 대처하기 위해서, 서베일런스, 공중 위생 인프라, 진단 기술 혁신이 진화함에 따라, 계속적인 성장이 전망되고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모(2024년)	1억 6,223만 달러
시장 규모(2030년)	2억 3,375만 달러
CAGR(2025-2030년)	6.42%
급성장 부문	핵산 증폭 검사(NAAT)
최대 시장	북미

시장 성장 촉진요인

지카바이러스 발생

주요 시장 과제

다른 감염과의 경쟁

주요 시장 동향

세계 모니터링 네트워크

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 목소리

제5장 세계의 지카바이러스 검사 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율 및 예측
  • 검사 유형별(핵산 증폭 검사(NAAT), 혈청학적 검사)
  • 지역별(북미, 유럽, 아시아태평양, 남미, 중동 및 아프리카)
  • 기업별(2024년)
• 검사 유형 시장 맵
  • 검사 유형별
  • 지역별

제6장 북미의 지카바이러스 검사 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 지카바이러스 검사 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 지카바이러스 검사 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 일본
  • 인도
  • 한국
  • 호주

제9장 남미의 지카바이러스 검사 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 지카바이러스 검사 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 중동 및 아프리카 : 국가별 분석
  • 아랍에미리트(UAE)
  • 사우디아라비아
  • 남아프리카

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향 및 발전

• 합병 및 인수
• 검사 유형 개발
• 최근 동향

제13장 Porter's Five Forces 분석

제14장 PESTEL 분석

제15장 경쟁 구도

• Quest Diagnostics, Inc.
• Chembio Diagnostic Systems, Inc.
• Biocan Diagnostics, Inc.
• DiaSorin SpA
• F. Hoffmann-La Roche Ltd.
• Siemens Healthineers AG
• SD Biosensors, Inc.

제16장 전략적 제안

제17장 기업 소개 및 면책사항

AJY

영문 목차

영문목차

The Global Zika Virus Testing Market was valued at USD 162.23 million in 2024 and is expected to grow at a CAGR of 6.42% through 2030. This market focuses on diagnostic technologies used to detect the Zika virus, a mosquito-borne pathogen known for its association with severe health outcomes, especially congenital defects in infants born to infected mothers. Testing methods include molecular diagnostics such as PCR, serological assays, and rapid diagnostic tests. Demand for these solutions intensifies during regional outbreaks, often prompting swift public health responses. Rising awareness of Zika's impact on maternal and neonatal health and global efforts to enhance infectious disease preparedness contribute to steady market expansion. Institutions like the CDC highlight the critical importance of early detection, particularly during early pregnancy, when the virus poses the highest risk. The sector is poised for continued growth as surveillance, public health infrastructure, and diagnostic innovation evolve to address emerging vector-borne threats.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 162.23 Million
Market Size 2030	USD 233.75 Million
CAGR 2025-2030	6.42%
Fastest Growing Segment	Nucleic Acid Amplification Testing (NAAT)
Largest Market	North America

Key Market Drivers

Zika Virus Outbreaks

Zika virus outbreaks play a pivotal role in driving the global demand for Zika virus testing. These outbreaks, typically concentrated in areas prone to mosquito-borne illnesses, create urgent public health challenges, triggering widespread diagnostic initiatives. The rapid transmission of the virus via the Aedes mosquito and its association with severe complications like microcephaly in newborns heighten the necessity for early and accurate detection. According to the CDC, first-trimester infections carry the highest risk, with 8% of affected pregnancies in U.S. regions leading to related birth defects. In response, health agencies deploy robust testing strategies aimed at curbing the spread and safeguarding at-risk populations. These efforts, often coordinated through government and international partnerships, lead to temporary surges in testing volumes and drive investment in diagnostics. The market's responsiveness to such health crises ensures its ongoing relevance and integration into emergency preparedness frameworks globally.

Key Market Challenges

Competition from Other Infectious Diseases

The Zika Virus Testing Market faces considerable challenges due to competing priorities in infectious disease management. Resources, funding, and healthcare attention are often directed toward higher-profile or more widespread diseases such as HIV/AIDS, tuberculosis, malaria, or emerging threats like COVID-19. This competition can limit the allocation of critical infrastructure and support for Zika-specific testing, slowing innovation, limiting deployment, and reducing public awareness. As healthcare systems balance multiple disease burdens, Zika testing may receive less focus unless an outbreak occurs, making sustained growth difficult. Ensuring Zika remains on the global health agenda requires coordinated efforts among governments, health organizations, and diagnostics companies to maintain testing readiness and infrastructure.

Key Market Trends

Global Surveillance Networks

A major trend shaping the Global Zika Virus Testing Market is the development and expansion of global surveillance networks. These collaborative systems integrate data collection, diagnostic standardization, and real-time information exchange to monitor the spread of the Zika virus. By fostering international cooperation, these networks enable timely identification of high-risk zones and facilitate proactive deployment of testing resources. Key components include harmonized testing protocols, shared insights on mosquito vectors, and integration with public health strategies. These surveillance systems not only enhance the responsiveness of testing operations but also influence diagnostic demand and guide investment in research. The strengthening of such global monitoring infrastructure supports early detection and containment, reinforcing the importance of diagnostic tools in managing vector-borne disease outbreaks.

Key Market Players

• Quest Diagnostics, Inc.
• Chembio Diagnostic Systems, Inc.
• Biocan Diagnostics, Inc.
• DiaSorin S.p.A.
• F. Hoffmann-La Roche Ltd.
• Siemens Healthineers AG
• SD Biosensors, Inc.

Report Scope:

In this report, the Global Zika Virus Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Zika Virus Testing Market, By Test Type:

• Nucleic Acid Amplification Testing (NAAT)
• Serological Testing

Zika Virus Testing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Zika Virus Testing Market.

Available Customizations:

Global Zika Virus Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Types
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Zika Virus Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Test Type (Nucleic Acid Amplification Testing (NAAT), Serological Testing)
  • 5.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.3. By Company (2024)
• 5.3. Test Type Market Map
  • 5.3.1. By Test Type
  • 5.3.2. By Region

6. North America Zika Virus Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Test Type
  • 6.2.2. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Zika Virus Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Test Type
  • 6.3.2. Canada Zika Virus Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Test Type
  • 6.3.3. Mexico Zika Virus Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Test Type

7. Europe Zika Virus Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Test Type
  • 7.2.2. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Zika Virus Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Test Type
  • 7.3.2. France Zika Virus Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Test Type
  • 7.3.3. United Kingdom Zika Virus Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Test Type
  • 7.3.4. Italy Zika Virus Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Test Type
  • 7.3.5. Spain Zika Virus Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Test Type

8. Asia-Pacific Zika Virus Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Test Type
  • 8.2.2. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Zika Virus Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Test Type
  • 8.3.2. Japan Zika Virus Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Test Type
  • 8.3.3. India Zika Virus Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Test Type
  • 8.3.4. South Korea Zika Virus Testing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Test Type
  • 8.3.5. Australia Zika Virus Testing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Test Type

9. South America Zika Virus Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Test Type
  • 9.2.2. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Zika Virus Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Test Type
  • 9.3.2. Argentina Zika Virus Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Test Type
  • 9.3.3. Colombia Zika Virus Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Test Type

10. Middle East and Africa Zika Virus Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Test Type
  • 10.2.2. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. UAE Zika Virus Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Test Type
  • 10.3.2. Saudi Arabia Zika Virus Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Test Type
  • 10.3.3. South Africa Zika Virus Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Test Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition
• 12.2. Test Type Development
• 12.3. Recent Developments

13. Porter's analysis

14. PESTEL analysis

15. Competitive Landscape

• 15.1. Quest Diagnostics, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Test Types & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
• 15.2. Chembio Diagnostic Systems, Inc.
• 15.3. Biocan Diagnostics, Inc.
• 15.4. DiaSorin S.p.A.
• 15.5. F. Hoffmann-La Roche Ltd.
• 15.6. Siemens Healthineers AG
• 15.7. SD Biosensors, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer

관련자료